High-dose Antibiotic Therapy Is Superior to a 3-Drug Combination of Prostanoids and Lipid A Derivative in Protecting Irradiated Canines
スポンサーリンク
概要
- 論文の詳細を見る
There is an urgent need to develop non-toxic radioprotectors. We tested the efficacy of a 3-drug combination (3-DC) of iloprost, misoprostol, and 3D-MPL (3-deacylated monophosphoryl lipid A) and the effects of postirradiation clinical support with high doses of antibiotics and blood transfusion. Canines were given 3-DC or the vehicle and exposed to 3.4 Gy or 4.1 Gy of 60Co radiation. Canines irradiated at 4.1 Gy were also given clinical support, which consisted of blood transfusion and antibiotics (gentamicin, and cefoxitin or cephalexin). Peripheral blood cell profile and 60-day survival were used as indices of protection. At 3.4 Gy, 3-DC- or vehicletreated canines without postirradiation clinical support survived only for 10 to 12 days. Fifty percent of the canines treated with 3-DC or vehicle and provided postirradiation clinical support survived 4.1-Gy irradiation. Survival of canines treated with vehicle before irradiation significantly correlated with postirradiation antibiotic treatments, but not with blood transfusion. The recovery profile of peripheral blood cells in 4.1 Gy-irradiated canines treated with vehicle and antibiotics was better than drug-treated canines. These results indicate that therapy with high doses of intramuscular aminoglycoside antibiotic (gentamicin) and an oral cephalosporin (cephalexin) enhanced survival of irradiated canines. Although blood transfusion correlated with survival of 3-DC treated canines, there were no additional survivors with 3-DC treated canines than the controls.
- 日本放射線影響学会の論文
著者
-
SEED THOMAS
Radiation Casualty Management
-
TOLES RAYMOND
Radiation Casualty Management
-
Kumar K.sree
Radiation Casualty Management Team Armed Forces Radiobiology Research Institute:united States Milita
-
Jackson William
Radiation Casualty Management
-
Seed Thomas
Radiation Casualty Management Team Armed Forces Radiobiology Research Institute:united States Milita
-
Miner Venita
Radiation Casualty Management Team Armed Forces Radiobiology Research Institute
-
Toles Raymond
Radiation Casualty Management Team Armed Forces Radiobiology Research Institute
-
SRINIVASAN V.
Radiation Casualty Management Team, Armed Forces Radiobiology Research Institute
-
Jackson William
Radiation Casualty Management Team Armed Forces Radiobiology Research Institute
-
Srinivasan V.
Radiation Casualty Management Team Armed Forces Radiobiology Research Institute
-
Kumar K.
Radiation Casualty Management Team, Armed Forces Radiobiology Research Institute
関連論文
- New Strategies for the Prevention of Radiation Injury: Possible Implications for Countering Radiation Hazards of Long-term Space Travel
- High-dose Antibiotic Therapy Is Superior to a 3-Drug Combination of Prostanoids and Lipid A Derivative in Protecting Irradiated Canines
- Hematopoietic Cell Crisis: An Early Stage of Evolving Myeloid Leukemia following Radiation Exposure